The scale-up, promotion and use of oral pre-exposure prophylaxis (PrEP) in different settings and in different populations.

PrEP programmes and uptake: latest news

PrEP programmes and uptake resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales, Scotland and Northern Ireland, PrEP is available through NHS sexual health clinics.It...

    From: Factsheets

    Information level Level 2

PrEP programmes and uptake news from aidsmap

More news

PrEP programmes and uptake news selected from other sources

  • Ireland: PrEP programme to reduce HIV rates to be rolled out later this year

    THE PrEP HIV prevention programme will be implemented in 2019, Health Minister Simon Harris said today. “We want to reduce the number of new HIV diagnoses in Ireland. Increasing the availability of PrEP will help us to do so. This report not only confirms that PrEP can help to prevent HIV amongst those who are high risk, it also shows how a PrEP programme could save money,” said Harris.

    17 June 2019 | Journal.ie
  • Ireland: HIV programme ‘will be undermined’ by lack of capacity

    Thousands of people are being turned away from sexual health clinics across the Republic, which will undermine a programme for preventing HIV due to be introduced later this year, according to Fianna Fáil. The PrEP (pre-exposure prophylaxis) HIV prevention programme is being implemented by the Government following advice from the State’s health watchdog that it would be safe and cost-effective.

    17 June 2019 | Irish Times
  • My PrEP Story: KUCHENGA (part 2)

    When a friend stays over, I notice the flash glance in the morning as I dole out my PrEP meds, hormones and vitamins from my divider and down them with citrus juice. Silence doesn’t ‘always’ speak volumes but in this case it does.

    11 June 2019 | Prepster
  • This drug could end HIV. Why hasn't it? (Podcast)

    Dr. Robert Grant developed a treatment — a daily pill known as pre-exposure prophylaxis, or PrEP — that could stop the AIDS crisis. We look at why that hasn’t happened.

    06 June 2019 | New York Times
  • Gay men in PROUD trial experienced high rates of intimate partner violence

    Screening for intimate partner violence should form part of sexual health services to reach vulnerable gay men.

    03 June 2019 | Avert
  • UK's biggest sexual health clinic has just dropped its PrEP prices

    PrEP has become more affordable at London’s leading sexual health clinic. The 56 Dean Street clinic opened its PrEP Shop in February last year and provides the HIV preventative medication for those eligible for NHS care. It will cost as little as £17.50 per month.

    02 June 2019 | Gay Star News
  • Q&A: Battling HIV PrEP stigma with Rep. Brian Sims

    To combat the stigma surrounding PrEP use, Pennsylvania state Rep. Brian Sims, D-Philadelphia, the first openly gay man to be elected to the Pennsylvania legislature, recently shared a photo of himself holding an FTC/TDF pill on Instagram.

    24 May 2019 | Healio
  • A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.

    A donation of H.I.V.-prevention drugs from the pharmaceutical giant Gilead could benefit shareholders more than patients.

    14 May 2019 | The New York Times (editorial)
  • Generic HIV prevention drug coming in 2020, Gilead says

    "Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early launch of a generic version of Truvada into the market in 2020, a year earlier than required," wrote Douglas Brooks, Gilead's executive director for community engagement, in an email shared with NBC News by the advocacy group PrEP4All.

    09 May 2019 | CNBC
  • Official Statement responding to Gilead Sciences’ announcement that it will allow Teva to Manufacture a Generic Version of Truvada

    While Gilead’s announcement that generic Truvada will be made available in the United States a year early is a victory for the LGBTQ+ community, for HIV activists, and for U.S. taxpayers, this should only be the beginning. Even their announcement today leaves Gilead with exclusive rights to Truvada as PrEP for another 15 months and Teva as the only generic manufacturer on the U.S. market. This will do little to reduce the price in a way that will increase access and PrEP4All remains suspicious of the terms and lack of transparency surrounding the Teva settlement.

    09 May 2019 | Breakthepatent.org
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.